Trial of Galcanezumab in Prevention of Episodic Cluster Headache

DOI Web Site 被引用文献4件
  • Peter J. Goadsby
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • David W. Dodick
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Massimo Leone
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Jennifer N. Bardos
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Tina M. Oakes
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Brian A. Millen
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Chunmei Zhou
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Sherie A. Dowsett
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Sheena K. Aurora
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Andrew H. Ahn
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Jyun-Yan Yang
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • Robert R. Conley
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).
  • James M. Martinez
    From the NIHR–Wellcome Trust King’s Clinical Research Facility and SLaM Biomedical Research Centre, King’s College London, and King’s College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ